Physician profile
Brian Yost
NPI 1528036837
$1,190.26
in general payments reported to CMS, 2019-2025
10 companies · $579 in 2025
The $579 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $21.06 · 2021: $18.96 · 2022: $11.95 · 2023: $24.31 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $331.05 | 2019 | |
| Stryker Corporation | $302.98 | 2019-2025 | Pangea, Gamma |
| Depuy Synthes Sales INC. | $275.43 | 2023-2025 | Na, Va-Lcp, Motoband |
| Argon Medical Devices, INC. | $102.94 | 2025 | Clot Management, Clot Management |
| Zimmer Biomet Holdings, INC. | $60.98 | 2019-2020 | |
| Wright Medical Technology, INC. | $50.18 | 2019 | |
| Pacira Therapeutics, INC. | $19.17 | 2019 | |
| Heraeus Medical, LLC. | $18.96 | 2021 | |
| Ermi LLC | $16.62 | 2019 | |
| Empire Medical, INC | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.